612 related articles for article (PubMed ID: 19253400)
1. Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease.
Muramatsu S; Okuno T; Suzuki Y; Nakayama T; Kakiuchi T; Takino N; Iida A; Ono F; Terao K; Inoue N; Nakano I; Kondo Y; Tsukada H
Synapse; 2009 Jul; 63(7):541-8. PubMed ID: 19253400
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
[TBL] [Abstract][Full Text] [Related]
3. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
[TBL] [Abstract][Full Text] [Related]
4. Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine-lesioned rats: implications for Parkinson's disease.
Shukla S; Agrawal AK; Chaturvedi RK; Seth K; Srivastava N; Sinha C; Shukla Y; Khanna VK; Seth PK
J Neurochem; 2004 Oct; 91(2):274-84. PubMed ID: 15447661
[TBL] [Abstract][Full Text] [Related]
5. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease.
Lindvall O; Sawle G; Widner H; Rothwell JC; Björklund A; Brooks D; Brundin P; Frackowiak R; Marsden CD; Odin P
Ann Neurol; 1994 Feb; 35(2):172-80. PubMed ID: 8109898
[TBL] [Abstract][Full Text] [Related]
6. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
7. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.
Kim JH; Auerbach JM; Rodríguez-Gómez JA; Velasco I; Gavin D; Lumelsky N; Lee SH; Nguyen J; Sánchez-Pernaute R; Bankiewicz K; McKay R
Nature; 2002 Jul; 418(6893):50-6. PubMed ID: 12077607
[TBL] [Abstract][Full Text] [Related]
8. Isolation and transplantation of dopaminergic neurons generated from mouse embryonic stem cells.
Yoshizaki T; Inaji M; Kouike H; Shimazaki T; Sawamoto K; Ando K; Date I; Kobayashi K; Suhara T; Uchiyama Y; Okano H
Neurosci Lett; 2004 Jun; 363(1):33-7. PubMed ID: 15157991
[TBL] [Abstract][Full Text] [Related]
9. Generation of dopamine neurons from embryonic stem cells in the presence of the neuralizing activity of bone marrow stromal cells derived from adult mice.
Shintani A; Nakao N; Kakishita K; Itakura T
J Neurosci Res; 2008 Oct; 86(13):2829-38. PubMed ID: 18561325
[TBL] [Abstract][Full Text] [Related]
10. Engineering a dopaminergic phenotype in stem/precursor cells: role of Nurr1, glia-derived signals, and Wnts.
Arenas E
Ann N Y Acad Sci; 2005 May; 1049():51-66. PubMed ID: 15965107
[TBL] [Abstract][Full Text] [Related]
11. The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model.
Cai J; Donaldson A; Yang M; German MS; Enikolopov G; Iacovitti L
Stem Cells; 2009 Jan; 27(1):220-9. PubMed ID: 18832589
[TBL] [Abstract][Full Text] [Related]
12. L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys.
Huot P; Lévesque M; Morissette M; Calon F; Dridi M; Di Paolo T; Parent A
J Chem Neuroanat; 2008 Jan; 35(1):77-84. PubMed ID: 17706922
[TBL] [Abstract][Full Text] [Related]
13. Induction of midbrain dopaminergic neurons from primate embryonic stem cells by coculture with sertoli cells.
Yue F; Cui L; Johkura K; Ogiwara N; Sasaki K
Stem Cells; 2006 Jul; 24(7):1695-706. PubMed ID: 16822882
[TBL] [Abstract][Full Text] [Related]
14. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.
Isacson O; Bjorklund LM; Schumacher JM
Ann Neurol; 2003; 53 Suppl 3():S135-46; discussion S146-8. PubMed ID: 12666105
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of embryonic stem cell-derived dopaminergic neurons in MPTP-treated monkeys.
Takahashi J; Takagi Y; Saiki H
Methods Mol Biol; 2009; 482():199-212. PubMed ID: 19089358
[TBL] [Abstract][Full Text] [Related]
16. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient.
Piccini P; Brooks DJ; Björklund A; Gunn RN; Grasby PM; Rimoldi O; Brundin P; Hagell P; Rehncrona S; Widner H; Lindvall O
Nat Neurosci; 1999 Dec; 2(12):1137-40. PubMed ID: 10570493
[TBL] [Abstract][Full Text] [Related]
17. Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study.
Thobois S; Vingerhoets F; Fraix V; Xie-Brustolin J; Mollion H; Costes N; Mertens P; Benabid AL; Pollak P; Broussolle E
Arch Neurol; 2004 Nov; 61(11):1705-9. PubMed ID: 15534182
[TBL] [Abstract][Full Text] [Related]
18. Derivation of functional dopamine neurons from embryonic stem cells.
Kim DS; Kim JY; Kang M; Cho MS; Kim DW
Cell Transplant; 2007; 16(2):117-23. PubMed ID: 17474293
[TBL] [Abstract][Full Text] [Related]
19. Pattern of long-term sensorimotor recovery following intrastriatal and--accumbens DA micrografts in a rat model of Parkinson's disease.
Falkenstein G; Rosenthal C; Reum T; Morgenstern R; Döbrössy M; Nikkhah G
J Comp Neurol; 2009 Jul; 515(1):41-55. PubMed ID: 19399892
[TBL] [Abstract][Full Text] [Related]
20. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease.
Lindvall O; Kokaia Z
Trends Pharmacol Sci; 2009 May; 30(5):260-7. PubMed ID: 19362379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]